Gene13
AADAC: arylacetamide deacetylase
Cite this record
ConductScience Library. AADAC: arylacetamide deacetylase. Genes, record 13. Release gene-search-2026-11-13-0.2.1, 13 Nov 2026. https://conductscience.org/library/genes/13
- Sources
- 13 sources
- Release
- gene-search-2026-11-13-0.2.1
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P22760 | Deacylase AADAC | 399 | 0 | Ensembl, GeneID, HGNC |
Source UniProt
Patents58
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| US 20260193644 A1 | 2026-07-09 | 586 | P22760 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 37897 | P22760 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 833 | P22760 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 586 | P22760 | Espacenet |
| US 20250320254 A1 | 2025-10-16 | 833 | P22760 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 586 | P22760 | Espacenet |
| JP 2025517970 A | 2025-06-12 | 833 | P22760 | Espacenet |
| JP 2025062604 A | 2025-04-14 | 6566 | P22760 | Espacenet |
| US 20250084141 A1 | 2025-03-13 | 20 | P22760 | Espacenet |
| US 12227549 B2 | 2025-02-18 | 20 | P22760 | Espacenet |
NIH grants296
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | AADAC papers | Newest fiscal year |
|---|---|---|---|
| D43TW009127 | Ethiopia-Emory TB Research Training Program | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
| P30CA056036 | Translational Research in Cancer | 2 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 2 | 2025 |
| P30DK026743 | UCSF Liver Center | 2 | 2025 |
| UM1AI068632 | IMPAACT Leadership Group | 2 | 2025 |
| UM1AI068634 | Statistical and Data Management Center (SDMC), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (ACTG) | 2 | 2025 |
| UM1AI068636 | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2 | 2025 |
| UM1AI106701 | AIDS Clinical Trial Group Laboratory Center | 2 | 2025 |
| F30CA250244 | Group 1 Innate Lymphoid Cell Dysregulation in Acute Myeloid Leukemia | 1 | 2025 |
Source NIH's project files
Papers442
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arylacetamide deacetylase plays a protective role against amodiaquine-induced liver injury by suppressing ferroptosis. | Chem Biol Interact | 2026 | 42562295 | PubTator, text mining | PubMed |
| Protein Abundance of Hydrolytic Drug Metabolizing Enzymes in Different Tissues and across Species. | J Med Chem | 2026 | 42342236 | PubTator, text mining | PubMed |
| Association of Arylacetamide Deacetylase-Mediated Extracellular Matrix Remodeling With Immune Exclusion in Pancreatic Cancer. | World J Oncol | 2026 | 42147260 | PubTator, text mining | PubMed |
| Histone methylation defines c-Jun/Sox2/Hif1α axis that controls stemness and tumor progression in squamous cell carcinoma. | Nat Commun | 2026 | 42045185 | PubTator, text mining | PubMed |
| Molnupiravir is not a selective CES2 probe substrate: in vitro evidence for CES1 involvement. | Drug Metab Dispos | 2026 | 41967311 | PubTator, text mining | PubMed |
| Composite nanovesicles for enhanced chemodynamic cancer therapy via decitabine-mediated epigenetic reactivation. | J Control Release | 2026 | 41871782 | PubTator, text mining | PubMed |
| In Silico Comparison of Rifampicin and 25-desacetyl Rifampicin-Induced PXR-Mediated CYP450 Transcriptional Response in 3D Primary Human Hepatocytes. | Bull Math Biol | 2026 | 41787130 | PubTator, text mining | PubMed |
| RRM1 inhibition sensitizes lung adenocarcinoma to decitabine treatment. | Cell Death Dis | 2026 | 41748545 | PubTator, text mining | PubMed |
| Detoxification of T-2 toxin in human chondrocytes due to its hydroxylation by carboxylesterases and arylacetamide deacetylase in the liver. | Food Chem Toxicol | 2026 | 41672295 | PubTator, text mining | PubMed |
| Circ_0041150 inhibits proliferation of pancreatic adenocarcinoma cells by regulating triglyceride accumulation via the miR-1178-3p/AADAC axis. | Discov Oncol | 2026 | 41642414 | PubTator, text mining | PubMed |
None in this release
- Drugs
- Trials
Sources 13
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
- USPTO's sequence listingsPublic domain in the US. Source: United States Patent and Trademark Office, www.uspto.gov
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
- USPTO's sequence listingsUSPTO's sequence listings of patents and published applications, from its bulk data files. No license named for the files. USPTO's terms say "most government-produced materials appearing on this website are not subject to copyright restrictions within the United States and are therefore in the public domain", and ask that USPTO be given appropriate acknowledgement ("Source: United States Patent and Trademark Office, www.uspto.gov"). USPTO does not endorse ConductScience or this release. Read on 12 Nov 2026 at https://www.uspto.gov/terms-use-uspto-websites
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
Source: United States Patent and Trademark Office, www.uspto.gov. USPTO does not endorse ConductScience or this database.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/13
GET https://conductscience.org/api/genes/v1/13/patents?page=2